COMMUNIQUÉS West-GlobeNewswire

Rapid Micro Biosystems to Participate at the PDA Pharmaceutical Microbiology Conference 2026
20/10/2026
LEXINGTON, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to [...]
STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026
20/10/2026
DUBLIN, IRELAND, Oct. 20, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2027 second quarter results at 9:00 a.m. ET [...]
Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million
20/10/2026
Proceeds strengthen balance sheet and provide expected cash runway into 2029 to advance SZN-8141 and SZN-8143 SOUTH SAN FRANCISCO, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (Surrozen or the Company) ( [...]
BioSyent to Present at Planet MicroCap Toronto
20/10/2026
MISSISSAUGA, Ontario, Oct. 20, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap investor conference in Toronto, Ontario from [...]
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
20/10/2026
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution 20. Oct 2026 / 23:50 CET/CEST, transmitted by [...]
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
20/10/2026
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution 20. Oct 2026 / 23:51 CET/CEST, transmitted by [...]
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
20/10/2026
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution 20. Oct 2026 / 23:52 CET/CEST, transmitted by [...]
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
20/10/2026
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution 20. Oct 2026 / 23:54 CET/CEST, transmitted by [...]
Correction: ITM and Lumara Bio Announce Dose-Response Analysis for ¹⁷⁷Lu-edotreotide (ITM-11) and Data Supporting Early-Stage Pipeline at EANM 2026
20/10/2026
Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in tumors and improved clinical response in GEP-NETs Separate independent, investigator-led [...]
Thought Leadership & Innovation Foundation Appoints Dr. Neena Haider to Board of Directors
20/10/2026
Renowned geneticist, precision medicine innovator and founder of Shifa Precision joins TLI leadership to advance science-driven solutions that improve health outcomes MCLEAN, Va., Oct. 20, 2026 (GLOBE NEWSWIRE) -- The [...]
EssilorLuxottica: Chiffre d'affaires T3 - Chiffre d’affaires en croissance de +9,0 % au T3, +7,2 % à taux de change constants
20/10/2026
Chiffre d’affaires en croissance de +9,0 % au T3, +7,2 % à taux de change constants Chiffre d’affaires du Groupe en hausse de +9,0 %, à 7 486 millions d’euros au T3, +7,2 % à taux de change constants¹, après une [...]
EssilorLuxottica: Q3 2026 Revenue - Revenue growth at 9.0% in Q3, +7.2% at constant currency
20/10/2026
Revenue growth at 9.0% in Q3, +7.2% at constant currency Group revenue +9.0% to Euro 7,486 million in Q3, +7.2% at constant ER 1 on top of double-digit growth of last year Group revenue +6.8% to Euro 22,304 million in [...]
La télésurveillance cardiaque au KFSH réduit de 46 % les hospitalisations liées à l’insuffisance cardiaque
20/10/2026
RIYAD, Arabie saoudite, 20 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a réduit de 46,4 % les hospitalisations pour insuffisance cardiaque décompensée chez les patients [...]
Le KFSH réduit de 75 % le temps d’attente aux urgences grâce à un système de gestion du flux de patients basés sur l’IA
20/10/2026
RIYAD, Arabie saoudite, 20 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a réduit de 75 % la durée d’attente médiane aux urgences de son établissement de Riyad, passant de [...]
Le KFSH inaugure une unité de cathétérisme cardiaque directement au sein des urgences afin d’accélérer la prise en charge des cas critiques
20/10/2026
RIYAD, Arabie saoudite, 20 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a mis en place un laboratoire de cathétérisme cardiaque au sein du service des urgences de son [...]
Inside information: Orion upgrades full-year outlook for 2026
20/10/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 20 OCTOBER 2026 at 20.20 EEST Inside information: Orion upgrades full-year outlook for 2026 Orion Corporation upgrades the full-year outlook for 2026 both [...]
Alignment Health Plan Recognized Among U.S. News & World Report’s 2027 Best Insurance Companies for Medicare Advantage
20/10/2026
Alignment earns “Best” rating in Arizona, California, Nevada, North Carolina and Texas for the second consecutive year, reflecting strong performance in care quality, prevention and satisfaction ORANGE, Calif., Oct. 20 [...]
Biomolecular Holdings Announces Issuance of Foundational Patent for Revolutionary Dimeric Fusion Protein Technology
20/10/2026
BURLINGAME, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Biomolecular Holdings LLC, a privately held biotechnology company advancing next-generation antibody architectures, today announced that the United States Patent and [...]
BioVie Presents Data on Bezisterim in Parkinson’s Disease at the 2026 American Neurological Association Annual Meeting
20/10/2026
Parkinson’s patients elevated baseline inflammation demonstrated statistically significant improvements in both motor and non-motor symptoms with Bezisterim compared to placebo. CARSON CITY, Nev., Oct. 20, 2026 (GLOBE [...]

Pages